Lawsuit Intelligencer Vol. I · No. 6 · October 2026

Lawsuit Intelligencer

Editorial analysis of mass torts, product liability, toxic exposure litigation, and the business of plaintiff-side law in the age of AI.

Lawsuit Intelligencer covers the lawsuits, regulations, referral systems, legal marketing practices, and technologies reshaping modern litigation. These are the questions consumer legal media and law firm marketing leave unasked.

Tracker

Interviews

Recent

  1. The Social Media Platforms' Insurers Are Making the Plaintiffs' Case

    To walk away from the social media addiction cases, Meta’s and Google’s liability insurers have to argue two things. The platforms were designed on purpose, and the harm to children was foreseeable. That is the plaintiffs’ theory of the case, argued by the defendants’ own carriers. A Delaware court accepted it in February, and the plaintiffs lost the insurance money in the same ruling.

    · Analysis · Insurance Coverage · 12 min read

  2. Who Reports Ozempic and GLP-1 Gastroparesis to the FDA

    The FDA’s adverse event database holds 5,699 reports tying gastroparesis to Ozempic and other GLP-1 drugs. Lawyers filed one in five of them, and 87% arrived after the MDL formed.

    · Analysis · Mass Tort Economics · 9 min read

  3. The Preparation Does Much of the Negotiating

    Elliott Portnoy now advises private equity sponsors on law firm MSO transactions. He explains why the plaintiff-side deals that close at higher multiples were mostly won a year before the first sponsor meeting.

    · Interview · The Business of Plaintiff-Side Law · 5 min read

  4. Cross-Examined by Your Own Chat Log

    Two federal courts divided in February over whether a party’s AI conversations are discoverable, and both were arguing about chats made for the case. In a mass tort the dangerous material sits years earlier, in a timestamped conversation the plaintiff has forgotten writing.

    · Analysis · Evidence and Discovery · 11 min read

  5. Courts Are Writing the AI Rules. They Won’t Let AI in the Room.

    A prospective juror researched a pending Georgia murder case and told the rest of the pool what he found, and the discharged panel cost the court $4,762.43. The same courts now deciding what AI companies owe the public forbid the technology in their own deliberations.

    · Analysis · Courts and Artificial Intelligence · 8 min read

  6. The Expert Has to Be Right the Same Way, Forty Times

    Josh Hyatt of Expert Institute on why a prior transcript sinks more experts than a thin CV does. A bellwether program demands something of a witness that a single case never will.

    · Interview · The Business of Plaintiff-Side Law · 6 min read

  7. Arizona v. L'Oréal Moves the Hair Relaxer Fight to Disclosure

    Arizona sued L'Oréal under a consumer fraud statute that needs no injured consumer. The case sits in Maricopa County while 11,779 federal cases wait on a causation ruling, and it asks what the company told buyers.

    · Analysis · Mass Tort Economics · 7 min read

  8. What Plaintiff Firms Get Wrong When They Buy Claimant Acquisition

    Brian Beck of Typhon Interactive puts numbers on the difference between a firm that works its leads and one that doesn’t. Mass arbitration, he says, is a technology problem before it is a media problem.

    · Interview · The Business of Plaintiff-Side Law · 7 min read

  9. The ChatGPT Log You Can’t Subpoena: Preserving Chat Evidence in AI Injury Litigation

    The Stored Communications Act blocks the third-party subpoena most practitioners reach for, and the order that suspended routine deletion terminated in September 2025. In the AI injury docket, the evidence case is won or lost in the first week of intake.

    · Analysis · Evidence and Discovery · 14 min read

  10. The AI Tort That Skips the Output Question

    Judge Lee held that Otter.ai is a third-party eavesdropper under CIPA not because the notetaker was uninvited, but because it trains on what it records. The theory reaches an AI company's balance sheet without anyone having to answer the product-or-content question first.

    · Coverage · AI Liability · 8 min read

Every article, by month →

Tools

From the Editor, Published Elsewhere

What We Cover

Mass Torts & Product Liability

PFAS, AFFF, talc, pharmaceutical and medical device litigation, MDL practice, and the doctrines moving through them.

The Business of Plaintiff-Side Law

Intake, referral economics, lead generation, legal marketing, AI in legal practice, firm consolidation, and the regulatory environment around all of it.

Regulation That Moves Litigation

Action by the EPA, FDA, FCC, state attorneys general, and state bars, analyzed for what it means in court rather than what the press release said.